Investigation of Low Back Pain Level on Symptoms in Chronic Consipation

Sponsor
Istanbul Medipol University Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT06073262
Collaborator
(none)
52
1
2.6
20

Study Details

Study Description

Brief Summary

Consipation is the most common digestive complaint in the general population

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Chronic constipation and low back pain are two common and often co-existing health conditions that affect millions of people worldwide. On the surface, these conditions appear to be unrelated and are associated with different anatomical sites (gastrointestinal tract and musculoskeletal system). However, a growing body of research is beginning to shed light on the complex interplay between chronic constipation and low back pain, highlighting potential links between these seemingly disparate health conditions. Common etiologic factors such as neuromuscular function, chronic inflammation and lifestyle-related variables are known to exist

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    52 participants
    Observational Model:
    Other
    Time Perspective:
    Other
    Official Title:
    Investigation of the Effect of Low Back Pain Level on Symptoms in Individuals With Chronic Consipation
    Actual Study Start Date :
    Oct 3, 2023
    Actual Primary Completion Date :
    Oct 3, 2023
    Anticipated Study Completion Date :
    Dec 21, 2023

    Arms and Interventions

    Arm Intervention/Treatment
    Non-specific low back pain individual with chronic consipation

    Individual without low back pain with chronic consipation

    Outcome Measures

    Primary Outcome Measures

    1. Bristol Stool Scale [one day]

      Lewis and Heaton classified the type of stool in 7 different groups in the scale. In the Bristol Stool Scale, the transit time of stool through the intestine is evaluated over seven different stool types. According to BGS, 1-2 points are shown as "hard stool", 3-4-5 points as "normal stool" and 6-7 points as "soft-watery stool (diarrhea)".

    2. Pelvic Pain Impact Questionnaire [one day]

      The questionnaire for clinical assessment of the impact of pelvic pain on women consists of 10 questions. However, the first 8 questions are scored. The range of scores to be obtained from the questionnaire varies between 1- 32. As the score value to be obtained from the questionnaire increases, the degree of functional limitation of pelvic pain on the person increases.

    3. Constipation Severity Scale [one day]

      Constipation Severity Scale (CSS) is a scale for determining the frequency, intensity and difficulty/difficulty during defecation. The scale includes 16 questions. The score that can be obtained from the DT sub-dimension is between 0-28, the score that can be obtained from the CBT sub-dimension is between 0-29, and the score that can be obtained from the Pain sub-dimension is between 0-16. The minimum total score that can be obtained from the KCS is 0 and the maximum score is 73. A high score on the scale indicates that the symptoms are serious. The highest score that can be obtained from the five-point Likert-type scale is 140 and the lowest score is 28. It is thought that quality of life is negatively affected as the scores obtained from the scale increase

    4. Disability level [one day]

      The Oswestry Disability Index is a commonly used outcome measure to detect perceived disability in patients with low back pain (12). This index consists of 10 items, 8 related to activities of daily living and 2 related to pain. Each item is scored from 0-5 and the total score is expressed as a percentage, with higher scores corresponding to more disability). Increasing scores on the Oswestry Disability Index indicate a higher level of disability.

    5. Autonomic nervous system device (Polar H10) [one day]

      The Polar H10 device is a heart rate sensor with the gold standard in high precision and accuracy that comes with a wearable chest strap. It can connect to multiple training devices via Bluetooth and ANT+. The device comes with a soft, adjustable sensor that contacts the chest to capture heart rate in real time. The study will evaluate the autonomic nervous system with the Polar H10 device. The data will be recorded by connecting the device to a smart phone via bluetooth and the software supported by the device will be used to analyze the data. The participant will be in a sitting position and a measurement will be made for 1 minute. In order for the device to make an accurate measurement, the electrode surface must be wetted before each measurement. The subject should not talk or move during the measurement.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 65 Years
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • 18-65 ages

    • Rome III diagnostic criteria

    Exclusion Criteria:
    • Severe heart or kidney diseaseprevious gastrointestinal, spinal or pelvic surgery other than cholecystectomy, hysterectomy or appendectomy neurological diseases such as

    • Multiple sclerosis, stroke, Parkinson's disease or spinal injury,

    • Impaired awareness (mini-mental score < 15),

    • Legal blindness, pregnancy,

    • Rectal prolapse

    • Anal fissure and altered constipation and diarrhea pattern.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 HAZAL genç Istanbul None Selected Turkey 34353

    Sponsors and Collaborators

    • Istanbul Medipol University Hospital

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    hazal genc, Principal Investigator, Istanbul Medipol University Hospital
    ClinicalTrials.gov Identifier:
    NCT06073262
    Other Study ID Numbers:
    • E-10840098-772.02-5856
    First Posted:
    Oct 10, 2023
    Last Update Posted:
    Oct 10, 2023
    Last Verified:
    Oct 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by hazal genc, Principal Investigator, Istanbul Medipol University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 10, 2023